Samsung Bioepis Co., Ltd. has signed a settlement and license agreement with Johnson Johnson concerning the commercialization of PYZCHIVA, a biosimilar to Stelara (ustekinumab)1, in Europe. The terms ...
Samsung Bioepis has signed a settlement and license agreement with Johnson & Johnson concerning the commercialization of ...
Zimbabwe has made significant strides towards achieving middle-income status, with many citizens now spending an average of US$9 per day, signaling improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback